Top compounds associated with response to SLC22A13


Feature Type Standardized
Nominal ANOVA
mRNA SNX-2112 GDSC1000 pan-cancer AAC -0.03 0.3
mRNA GSK-650394 GDSC1000 pan-cancer AAC 0.035 0.3
mRNA methylstat CTRPv2 pan-cancer AAC -0.043 0.3
mRNA tamatinib CTRPv2 pan-cancer AAC -0.039 0.3
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.035 0.3
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.037 0.3
mRNA BRD-K24690302 CTRPv2 pan-cancer AAC -0.038 0.3
mRNA decitabine CTRPv2 pan-cancer AAC -0.028 0.3
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC -0.038 0.3
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.035 0.3
Download CSV